Eton Pharmaceuticals, Inc. (ETON)
62.94
-1.49
(-2.31%)
USD |
NASDAQ |
Aug 25, 16:00
63.98
+1.04
(+1.65%)
After-Hours: 19:59
Eton Pharmaceuticals Price to Book Value : 38.22 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 39.13 |
| August 21, 2026 | 38.54 |
| August 20, 2026 | 36.38 |
| August 19, 2026 | 37.34 |
| August 18, 2026 | 38.52 |
| August 17, 2026 | 37.49 |
| August 14, 2026 | 35.74 |
| August 13, 2026 | 24.78 |
| August 12, 2026 | 25.25 |
| August 11, 2026 | 25.54 |
| August 10, 2026 | 26.52 |
| August 07, 2026 | 27.08 |
| August 06, 2026 | 28.04 |
| August 05, 2026 | 27.92 |
| August 04, 2026 | 27.83 |
| August 03, 2026 | 27.41 |
| July 31, 2026 | 28.19 |
| July 30, 2026 | 29.77 |
| July 29, 2026 | 29.23 |
| July 28, 2026 | 28.34 |
| July 27, 2026 | 25.69 |
| July 24, 2026 | 25.86 |
| July 23, 2026 | 26.81 |
| July 22, 2026 | 26.46 |
| July 21, 2026 | 26.23 |
| Date | Value |
|---|---|
| July 20, 2026 | 24.94 |
| July 17, 2026 | 25.70 |
| July 16, 2026 | 22.58 |
| July 15, 2026 | 23.38 |
| July 14, 2026 | 22.78 |
| July 13, 2026 | 22.68 |
| July 10, 2026 | 22.23 |
| July 09, 2026 | 22.67 |
| July 08, 2026 | 21.97 |
| July 07, 2026 | 22.92 |
| July 06, 2026 | 23.09 |
| July 02, 2026 | 22.77 |
| July 01, 2026 | 22.24 |
| June 30, 2026 | 21.98 |
| June 29, 2026 | 32.82 |
| June 26, 2026 | 31.90 |
| June 25, 2026 | 31.12 |
| June 24, 2026 | 30.37 |
| June 23, 2026 | 29.93 |
| June 22, 2026 | 29.24 |
| June 18, 2026 | 29.03 |
| June 17, 2026 | 29.28 |
| June 16, 2026 | 28.91 |
| June 15, 2026 | 28.73 |
| June 12, 2026 | 28.23 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Nektar Therapeutics | 2.831 |
| Pfizer Inc. | 1.911 |
| Elite Pharmaceuticals, Inc. | 2.971 |
| Daré Bioscience, Inc. | -- |
| Liquidia Corp. | 32.22 |
Price to Book Value Related Metrics
| PE Ratio | 166.38 |
| PS Ratio | 18.25 |
| Price | 62.94 |
| Earnings Yield | 0.60% |
| Market Cap | 1.781B |
| Operating PE Ratio | 116.75 |
| Normalized PE Ratio | 164.21 |